Arvest Investments Inc. Boosts Stock Holdings in Molina Healthcare, Inc. (NYSE:MOH)

Arvest Investments Inc. raised its position in shares of Molina Healthcare, Inc. (NYSE:MOH) by 15.2% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,664 shares of the company’s stock after purchasing an additional 352 shares during the period. Arvest Investments Inc.’s holdings in Molina Healthcare were worth $918,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Innealta Capital LLC purchased a new stake in shares of Molina Healthcare during the 2nd quarter valued at approximately $36,000. Ashton Thomas Private Wealth LLC bought a new position in shares of Molina Healthcare in the second quarter worth $40,000. AM Squared Ltd purchased a new position in shares of Molina Healthcare in the second quarter valued at $59,000. Capital Performance Advisors LLP purchased a new position in shares of Molina Healthcare in the third quarter valued at $62,000. Finally, UMB Bank n.a. lifted its holdings in Molina Healthcare by 96.2% during the 3rd quarter. UMB Bank n.a. now owns 206 shares of the company’s stock worth $71,000 after purchasing an additional 101 shares in the last quarter. 98.50% of the stock is currently owned by institutional investors.

Insider Buying and Selling

In other news, CAO Maurice Hebert sold 393 shares of the stock in a transaction that occurred on Thursday, August 15th. The stock was sold at an average price of $346.52, for a total transaction of $136,182.36. Following the completion of the sale, the chief accounting officer now owns 9,473 shares of the company’s stock, valued at approximately $3,282,583.96. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. 1.10% of the stock is owned by corporate insiders.

Molina Healthcare Trading Down 2.4 %

Shares of MOH traded down $8.04 during mid-day trading on Friday, reaching $329.65. The company’s stock had a trading volume of 1,009,526 shares, compared to its average volume of 969,300. Molina Healthcare, Inc. has a 52 week low of $272.69 and a 52 week high of $423.92. The stock has a market cap of $18.86 billion, a PE ratio of 16.74, a P/E/G ratio of 1.12 and a beta of 0.59. The company’s fifty day moving average price is $330.97 and its two-hundred day moving average price is $326.97. The company has a current ratio of 1.54, a quick ratio of 1.55 and a debt-to-equity ratio of 0.53.

Molina Healthcare (NYSE:MOH) last posted its quarterly earnings results on Wednesday, October 23rd. The company reported $6.01 earnings per share for the quarter, topping the consensus estimate of $5.96 by $0.05. Molina Healthcare had a net margin of 2.92% and a return on equity of 27.88%. The business had revenue of $10.34 billion during the quarter, compared to the consensus estimate of $9.92 billion. During the same period in the previous year, the firm posted $5.05 earnings per share. The firm’s revenue for the quarter was up 21.0% on a year-over-year basis. On average, analysts predict that Molina Healthcare, Inc. will post 23.44 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

MOH has been the topic of several analyst reports. Truist Financial decreased their price target on Molina Healthcare from $440.00 to $400.00 and set a “buy” rating on the stock in a research report on Monday, July 15th. Stephens reaffirmed an “equal weight” rating and issued a $320.00 price target on shares of Molina Healthcare in a report on Thursday, July 25th. StockNews.com upgraded Molina Healthcare from a “hold” rating to a “buy” rating in a research report on Friday, October 18th. TD Cowen reduced their target price on Molina Healthcare from $412.00 to $351.00 and set a “buy” rating for the company in a research report on Wednesday, July 24th. Finally, Barclays raised their price target on Molina Healthcare from $359.00 to $372.00 and gave the company an “equal weight” rating in a report on Friday, October 25th. One research analyst has rated the stock with a sell rating, six have issued a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, Molina Healthcare has an average rating of “Moderate Buy” and an average price target of $367.17.

Molina Healthcare Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.